STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come

Researchers at a pancreatic cancer conference in London highlighted a new drug showing milestone clinical trial results, compared to checkpoint inhibitors in cancer treatment. The drug's progress has generated excitement among experts, though challenges remain ahead.